We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) closed the most recent trading day at $127.75, moving +1.93% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 1.08%. On the other hand, the Dow registered a gain of 0.92%, and the technology-centric Nasdaq increased by 1.41%.
Shares of the hospital operator witnessed a loss of 7.1% over the previous month, trailing the performance of the Medical sector with its gain of 0.21% and outperforming the S&P 500's loss of 8.26%.
The upcoming earnings release of Tenet Healthcare will be of great interest to investors. It is anticipated that the company will report an EPS of $3.10, marking a 3.73% fall compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $5.18 billion, down 3.53% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.03 per share and revenue of $20.84 billion, which would represent changes of +1.26% and +0.87%, respectively, from the prior year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Tenet Healthcare. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 1.1% lower. Tenet Healthcare is currently sporting a Zacks Rank of #3 (Hold).
Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 10.41. This signifies a premium in comparison to the average Forward P/E of 10.17 for its industry.
We can also see that THC currently has a PEG ratio of 0.95. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Hospital was holding an average PEG ratio of 1.04 at yesterday's closing price.
The Medical - Hospital industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 167, finds itself in the bottom 34% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
Tenet Healthcare (THC - Free Report) closed the most recent trading day at $127.75, moving +1.93% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 1.08%. On the other hand, the Dow registered a gain of 0.92%, and the technology-centric Nasdaq increased by 1.41%.
Shares of the hospital operator witnessed a loss of 7.1% over the previous month, trailing the performance of the Medical sector with its gain of 0.21% and outperforming the S&P 500's loss of 8.26%.
The upcoming earnings release of Tenet Healthcare will be of great interest to investors. It is anticipated that the company will report an EPS of $3.10, marking a 3.73% fall compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $5.18 billion, down 3.53% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.03 per share and revenue of $20.84 billion, which would represent changes of +1.26% and +0.87%, respectively, from the prior year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Tenet Healthcare. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 1.1% lower. Tenet Healthcare is currently sporting a Zacks Rank of #3 (Hold).
Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 10.41. This signifies a premium in comparison to the average Forward P/E of 10.17 for its industry.
We can also see that THC currently has a PEG ratio of 0.95. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Hospital was holding an average PEG ratio of 1.04 at yesterday's closing price.
The Medical - Hospital industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 167, finds itself in the bottom 34% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.